News Quantified

CDNA – caredx, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting

CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing [Yahoo! Finance]

CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing [Yahoo! Finance]

CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing

Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns [Yahoo! Finance]

-4.1%

BEAT

13.8%

BEAT

-7.9%

BEAT

-10.7%

BEAT

Form 4 CareDx, Inc. For: Apr 16 Filed by: Hanna John Walter JR

Form 144 CareDx, Inc. Filed by: Hanna John Walter JR

Form 4 CareDx, Inc. For: Apr 15 Filed by: Hanna John Walter JR

Form 8-K CareDx, Inc. For: Apr 15

Form 4 CareDx, Inc. For: Apr 06 Filed by: Novack Jeffrey Adam

Top News Gainers

3/13 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 17.3%

4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%

5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%

1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%

4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%

9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%

10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%

5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%

3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%

6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%

Top News Decliners

3/16 Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter -19.3%

7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%

8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%

10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%

11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%

3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%

6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%

8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%

7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%

10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day